FI851449L - 9a-aza-9a-homoerytromycinderivat. - Google Patents

9a-aza-9a-homoerytromycinderivat.

Info

Publication number
FI851449L
FI851449L FI851449A FI851449A FI851449L FI 851449 L FI851449 L FI 851449L FI 851449 A FI851449 A FI 851449A FI 851449 A FI851449 A FI 851449A FI 851449 L FI851449 L FI 851449L
Authority
FI
Finland
Prior art keywords
homoerytromycinderivat
aza
Prior art date
Application number
FI851449A
Other languages
English (en)
Finnish (fi)
Other versions
FI851449A0 (fi
Inventor
James Robert Hauske
Arthur Adam Nagel
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/600,252 external-priority patent/US4512982A/en
Application filed by Pfizer filed Critical Pfizer
Publication of FI851449A0 publication Critical patent/FI851449A0/fi
Publication of FI851449L publication Critical patent/FI851449L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI851449A 1984-04-13 1985-04-11 9a-aza-9a-homoerytromycinderivat. FI851449L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/600,252 US4512982A (en) 1984-04-13 1984-04-13 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US06/616,529 US4518590A (en) 1984-04-13 1984-06-04 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method

Publications (2)

Publication Number Publication Date
FI851449A0 FI851449A0 (fi) 1985-04-11
FI851449L true FI851449L (fi) 1985-10-14

Family

ID=27083554

Family Applications (1)

Application Number Title Priority Date Filing Date
FI851449A FI851449L (fi) 1984-04-13 1985-04-11 9a-aza-9a-homoerytromycinderivat.

Country Status (19)

Country Link
US (1) US4518590A (fr)
EP (1) EP0159856B1 (fr)
KR (1) KR860002111B1 (fr)
AU (1) AU549235B2 (fr)
CA (1) CA1234805A (fr)
DE (1) DE3565267D1 (fr)
DK (1) DK164785A (fr)
EG (1) EG17459A (fr)
ES (3) ES8607335A1 (fr)
FI (1) FI851449L (fr)
GR (1) GR850900B (fr)
HU (1) HU195668B (fr)
IE (1) IE57739B1 (fr)
IL (1) IL74865A (fr)
NO (1) NO161497C (fr)
NZ (1) NZ211769A (fr)
PH (1) PH21185A (fr)
PT (1) PT80270B (fr)
YU (3) YU62385A (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
US4904644A (en) * 1988-08-03 1990-02-27 Schering Corporation Antimicrobial compound isolated from Actinomadura fulva subsp indica
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
EP0503932B1 (fr) 1991-03-15 1998-12-02 Merck & Co. Inc. 9-deoxo-9(Z)-hydroxyiminoérythromycine A et ses dérivés
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5538961A (en) * 1991-04-09 1996-07-23 Abbott Laboratories Macrocyclic lactam prokinetic agents
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
ATE154806T1 (de) * 1993-05-19 1997-07-15 Pfizer Zwischenprodukt für azithromycin
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
FR2739620B1 (fr) * 1995-10-09 1997-12-19 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-o-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
USRE38426E1 (en) * 1995-10-09 2004-02-10 Aventis Pharma S.A. 5-O-deosaminyl 6-O-methyl erythronolide A derivatives, preparation method therefor and use thereof for preparing biologically active materials
DE60114028T2 (de) * 2000-08-23 2006-07-13 Wockhardt Ltd. Verfahren zur herstellung von wasserfreiem azithromycin
BR0209241A (pt) 2001-04-27 2004-06-15 Pfizer Prod Inc Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida
CA2476423A1 (fr) 2002-02-15 2003-08-28 Sympore Gmbh Conjugues de composes biologiquement actifs, procedes de preparation et d'utilisation, et formulation et applications pharmaceutiques
EP1483579A4 (fr) 2002-02-15 2006-07-12 Merckle Gmbh Conjugues de composes biologiquement actifs, methodes de preparation et d'utilisation des conjugues, formulation et applications pharmaceutiques obtenues a partir desdits conjugues
NZ535355A (en) 2002-02-15 2007-09-28 Merckle Gmbh Antibiotic conjugates
GB0310992D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
YU43116B (en) * 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor

Also Published As

Publication number Publication date
AU549235B2 (en) 1986-01-23
FI851449A0 (fi) 1985-04-11
CA1234805A (fr) 1988-04-05
ES551503A0 (es) 1987-04-16
HU195668B (en) 1988-06-28
DK164785D0 (da) 1985-04-12
NZ211769A (en) 1987-10-30
KR850007435A (ko) 1985-12-04
AU4107085A (en) 1985-10-17
EP0159856B1 (fr) 1988-09-28
PH21185A (en) 1987-08-12
YU62385A (en) 1988-02-29
YU126887A (en) 1988-02-29
IL74865A0 (en) 1985-07-31
NO161497B (no) 1989-05-16
IE850912L (en) 1985-10-13
HUT37629A (en) 1986-01-23
KR860002111B1 (ko) 1986-11-26
ES542134A0 (es) 1986-06-16
PT80270A (en) 1985-05-01
NO851466L (no) 1985-10-14
US4518590A (en) 1985-05-21
ES551502A0 (es) 1987-05-01
ES8704965A1 (es) 1987-04-16
YU126787A (en) 1988-02-29
PT80270B (pt) 1987-10-20
EG17459A (en) 1992-12-30
DK164785A (da) 1985-12-10
NO161497C (no) 1989-08-23
IL74865A (en) 1987-12-31
DE3565267D1 (en) 1988-11-03
EP0159856A2 (fr) 1985-10-30
ES8705458A1 (es) 1987-05-01
ES8607335A1 (es) 1986-06-16
IE57739B1 (en) 1993-03-24
EP0159856A3 (en) 1986-03-19
GR850900B (fr) 1985-11-25

Similar Documents

Publication Publication Date Title
DE3583455D1 (de) Salbenbase.
DE3581430D1 (de) Detergens.
DE3576268D1 (de) Hoergeraet.
ATE41922T1 (de) Alkylsulfonamidophenylalkylamine.
DE3585265D1 (de) Fibronektinpraeparate.
DE3581707D1 (de) Neigungsmesser.
DE3583080D1 (de) Mikrorechner.
FI851449A0 (fi) 9a-aza-9a-homoerytromycinderivat.
FI853566L (fi) Kabelgenomfoering.
NO854901L (no) Fluid-proevetaker.
FI850791A0 (fi) Roekdetektor.
DE3578421D1 (de) Glycidyloxydiketone.
DE3582060D1 (de) Homopropargylamine.
FI73926B (fi) Standardhastighetsregulator foer motorfordon.
FI843030A (fi) Faestanordning foer klaedesplagg.
DE3584628D1 (de) Xenocoumacine.
DE3577708D1 (de) Diphenylhexafluorpropanabkoemmlinge.
DE3586085D1 (de) Antitumor-4-hydroxy-2-zyklopentenonen.
FI850944L (fi) Hydrocyklon separatorapparat.
FI851961A0 (fi) Skenvaexel.
DE3587711D1 (de) Minaktivin.
DE3574867D1 (de) Aminokarnitine.
DE3574494D1 (de) Selbstzerlegerzuender.
DE3576291D1 (de) Entaester.
FI853485A0 (fi) Brandfoerhindrande dispersionsfaerg.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: PFIZER INC.